News from the Pacific Northwest Node: Updates from CTN-0082 and CTN-0102-XR

CTN-0082 update

CTN-0082 had another paper published: Predicting Willingness to Use MOUD: An Application of the Theory of Reasoned Action and Theory of Planned-Behavior. Lancaster C, et al. Journal of Drug Issues 2025 (in press).

The paper reports on a study that used the Theory of Reasoned Action (TRA) and Theory of Planned Behavior (TPB) to assess willingness to use 3 medications (methadone, buprenorphine, naltrexone) for opioid use disorder (MOUD) among people who use opioids (PWUOs). Findings partially supported the TRA but not TPB, with positive attitudes associated with greater willingness to use all three types of MOUD, pointing to the value of syringe services programs as a low threshold hub for treatment engagement.

CTN-0102-XR update

Providence Northeast Washington Medical Group – Colville finished all participant involvement in CTN-102-XR ending with an unheard of 100% retention rate! We want to send a huge congratulations to the team in Colville for their excellent work engaging participants and providing top notch care!